
Curie AI, a healthcare startup from SRI International (formerly the Stanford Research Institute), is a first-of-its-kind virtual respiratory care program that makes it easy to provide supplemental personalized disease management for your high-risk patients.
Meet Curie AIWe’re currently partnered with:



Curie AI has developed a patented passive monitoring technology for recognizing the respiratory symptoms patients experience while sleeping. It is delivered through a simple user interface that results in a 98% adherence to daily usage.
Our Actionable Insights engine then delivers the most accurate insights from the monitoring data to the clinical team in order to provide personalized proactive care for every patient.
Our passive contactless monitoring
technology is a tablet that sits on the
nightstand.
With the world’s largest respiratory biomarker dataset of over 1 million hours, our AI will deliver the most accurate and actionable insights to our clinical team to create, and proactively adjust, the best possible treatment plan.
Our skilled respiratory clinicians have every patient's current and historical data at their fingertips right in the Curie AI dashboard. Our clinicians can message or video chat directly with patients to deliver a truly personalized experience.
Here are a few of the benefits from integrating Curie AI into your patient treatment planning.

60% reduction in rescue inhaler use
Our clinical team uses patient insights to be more proactive with adjustments to treatment plans that creates a more stable condition and reduces the need for a rescue inhaler.

80% reduction in ER and hospitalizations visits
With Curie AI's proactive model, patients are more in control and understand how to manage their conditions to avoid the ambulance.

$354/mo increase in
revenue per patient
New CPT codes for remote monitoring and chronic care management can bring increased revenue to your practice for every COPD Medicare patient.